First Manhattan CO Johnson & Johnson Transaction History

First Manhattan CO

$29.7 Billion
Q2 2024

A detailed history of First Manhattan CO transactions in Johnson & Johnson stock. As of the latest transaction made, First Manhattan CO holds 978,889 shares of JNJ stock, worth $152 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

978,889

Previous 978,889 -0.0%

Holding current value

$152 Million

Previous $143 Million -0.0%

% of portfolio

0.48%

Previous 0.48%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $2.33 Million - $2.55 Million	-16,156 Reduced 1.62%	978,889 $143 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $9.93 Million - $10.4 Million	-63,961 Reduced 6.04%	995,045 $157 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $7.7 Million - $8.4 Million	-52,897 Reduced 4.76%	1,059,006 $166 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $18.2 Million - $20.4 Million	-116,656 Reduced 9.5%	1,111,903 $173 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $24.2 Million - $26.1 Million	-156,895 Reduced 11.32%	1,228,559 $203 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $17.4 Million - $20.8 Million	-115,456 Reduced 7.69%	1,385,454 $215 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $977,540 - $1.1 Million	6,102 Added 0.41%	1,500,910 $265 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $8.08 Million - $8.99 Million	-50,057 Reduced 3.24%	1,494,808 $244 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $10.6 Million - $11.7 Million	-63,132 Reduced 3.93%	1,544,865 $274 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $41.6 Million - $47.2 Million	-263,035 Reduced 14.06%	1,607,997 $285 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $1.82 Million - $2.02 Million	11,689 Added 0.63%	1,871,032 $320 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $5.49 Million - $6.1 Million	-34,000 Reduced 1.8%	1,859,343 $300 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $1.77 Million - $1.9 Million	-11,109 Reduced 0.58%	1,893,343 $312 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $3.79 Million - $4.22 Million	-24,777 Reduced 1.28%	1,904,452 $313 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $5.28 Million - $6.06 Million	-38,534 Reduced 1.96%	1,929,229 $304 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $21.5 Million - $23.5 Million	-153,086 Reduced 7.22%	1,967,763 $293 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $16.2 Million - $19.6 Million	-125,899 Reduced 5.6%	2,120,849 $298 Million
Q1 2020 May 06, 2020	SELL	$111.14 - $153.99 $6.06 Million - $8.4 Million	-54,523 Reduced 2.37%	2,246,748 $295 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $4.96 Million - $5.7 Million	-38,915 Reduced 1.66%	2,301,271 $336 Million
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $9.35 Million - $10.5 Million	73,658 Added 3.25%	2,340,186 $303 Million
Q2 2019 Aug 16, 2019	SELL	$131.15 - $144.24 $233,447 - $256,747	-1,780 Reduced 0.08%	2,266,528 $316 Million
Q1 2019 Apr 12, 2019	SELL	$125.72 - $139.79 $8.04 Million - $8.94 Million	-63,947 Reduced 2.74%	2,268,308 $317 Million
Q4 2018 Jan 30, 2019	BUY	$122.84 - $147.84 $164,605 - $198,105	1,340 Added 0.06%	2,332,255 $301 Million
Q3 2018 Oct 15, 2018	SELL	$121.58 - $142.88 $2.16 Million - $2.54 Million	-17,806 Reduced 0.76%	2,330,915 $322 Million
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $6.57 Million - $7.25 Million	-55,033 Reduced 2.29%	2,348,721 $285 Million
Q1 2018 Apr 20, 2018	BUY	$125.1 - $148.14 $3.44 Million - $4.08 Million	27,526 Added 1.16%	2,403,754 $308 Million
Q4 2017 Jan 22, 2018	SELL	$131.22 - $143.62 $8.98 Million - $9.82 Million	-68,407 Reduced 2.8%	2,376,228 $332 Million
Q3 2017 Oct 25, 2017	BUY	$129.47 - $135.38 $317 Million - $331 Million	2,444,635	2,444,635 $318 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Johnson & Johnson Transaction History